WAUKESHA, Wis. – August 17, 2015 – GE Healthcare is proud to be the first company with a low dose computed tomography (CT) lung cancer screening option[i] that is cleared by the U.S. FDA for lung cancer screening.[ii] Both the U.S.
http://www.genewsroom.com/press-releases/ge-healthcare-first-receive-fda-clearance-low-dose-ct-lung-cancer-screening-281508